Sort
50,496 grants matching “lung cancer”
Spatiotemporal Analysis of Disparities in Ovarian Cancer Treatment and Survival
$386,250Robert Edward Bristow · University Of California-Irvine · R01 · FY2020 · MD
Genetic information transfer to hematopoietic cells: Role of microvesicles
$386,250Peter J Quesenberry · Rhode Island Hospital · R01 · FY2012 · HL
Characterization of a Model System to Advance Triple-Stranded RNA Biology
$386,250Jessica Ann Brown · University Of Notre Dame · R35 · FY2021 · GM
Characterization of a Model System to Advance Triple-Stranded RNA Biology
$386,250Jessica Ann Brown · University Of Notre Dame · R35 · FY2022 · GM
Use of senolytics to enhance chemotherapeutic efficacy in lung cancer
$386,245David A. Gewirtz · Virginia Commonwealth University · R01 · FY2022 · CA
Impact of quercetin on inflammatory and oxidative stress markers in COPD
$386,229Umadevi Sivanappa Sajjan · Temple Univ Of The Commonwealth · R33 · FY2022 · AT
(PQA1) The antipsychotic thioridazine protects against medulloblastoma (MB): volu
$386,223Lily Y Jan · University Of California, San Francisco · R01 · FY2014 · CA
HIF- 2ALPHA, Hypoxic Gene Regulation, and Angiogenesis
$386,213M. Celeste Simon · University Of Pennsylvania · R01 · FY2011 · HL
Targeted tumoricidal bacteria
$386,199Ming Zhao · Anticancer, Inc. · R44 · FY2011 · CA
Detecting DICER1: A global partnership to cure pediatric lung cancer
$386,196Kris Ann Pinekenstein Schultz · Children'S Hospitals And Clinics · R37 · FY2025 · CA
Revealing masked specificities of human Nuclear Receptors
$386,185Aseem Z Ansari · University Of Wisconsin-Madison · R01 · FY2016 · GM
Development of a5 nicotinic receptor agonists for smoking cessation
$386,184Brigitte Angenieux · Ophidion, Inc. · R44 · FY2015 · DA
Controlled Release of Macromolecules
$386,153Robert S Langer · Massachusetts Institute Of Technology · R37 · FY2011 · EB
Outreach Program
$386,149Elba Diaz · University Of Puerto Rico Med Sciences · U54 · FY2010 · CA
Clinical Trials of FTI Radiosensitization
$386,139University Of Pennsylvania · R01 · FY2005 · CA
Clinical Trials of FTI Radiosensitization
$386,139University Of Pennsylvania · R01 · FY2004 · CA
Clinical Trials of FTI Radiosensitization
$386,139University Of Pennsylvania · R01 · FY2003 · CA
The role of Nrf2 in mediating resistance to EGFR inhibition in glioblastoma
$386,138Amyn Habib · Ut Southwestern Medical Center · R01 · FY2020 · CA
TRANSGENIC MOUSE MODELS FOR STUDYING PROSTATE/GU DISEASE
$386,125Washington University · R01 · FY2000 · DK
METABOLISM OF CARCINOGENIC TOBACCO SPECIFIC NITROSAMINES
$386,106University Of Minnesota Twin Cities · R01 · FY2003 · CA
Lung regeneration and the stem cell niche
$386,100Stijn Piet Johan De Langhe · National Jewish Health · R01 · FY2012 · HL
Incident cancer studies in a unique arsenic-exposed area of Chile
$386,086Craig M Steinmaus · University Of California Berkeley · R01 · FY2008 · ES
Defining the Critical Function and Regulation of NNMT in Breast Cancer Progression and Metastasis
$386,068Binhua P Zhou · University Of Kentucky · R01 · FY2023 · CA
Influence of intra-individual variability in serial screening samples on clinical decision-making for risk stratification and biopsy by a single PSA and additional markers
$386,067Sigrid Carlsson · Sloan-Kettering Inst Can Research · U01 · FY2023 · CA
Defining the Critical Function and Regulation of NNMT in Breast Cancer Progression and Metastasis
$386,065Binhua P Zhou · University Of Kentucky · R01 · FY2022 · CA